Advancing Target Identification & Validation Using Complex 3D Models to Overcome Animal Model Limitations
3:30 pm - Thursday 30th April 2026
- Establishing 3D model systems for target translatability to address gaps where animal models lack relevant therapeutic targets
- Contrasting 2D versus 3D model capabilities to demonstrate complex system advantages and secure essential leadership investment support
- Implementing rapid model qualification workflows in fast-paced biopharma environments to accelerate target validation and therapeutic development timelines
